EMERITI PHARMA AB has a total of 14 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2010. It filed its patents most often in Australia, United Kingdom and United States. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are MERLION PHARMACEUTICALS PTE LTD, ALTEON INC and KHONDRION IP B V.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 2 | |
#2 | United Kingdom | 2 | |
#3 | United States | 2 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | EAPO (Eurasian Patent Organization) | 1 | |
#8 | EPO (European Patent Office) | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Mexico | 1 | |
#11 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Specific use of cosmetics |
# | Name | Total Patents |
---|---|---|
#1 | Fex Tomas | 10 |
#2 | Gustafsson Nils David | 8 |
#3 | Nils David Gustafsson | 2 |
#4 | Schell Peter | 2 |
#5 | Pettersen Daniel | 2 |
#6 | Cheng Leifeng | 2 |
#7 | Tomas Fex | 2 |
#8 | Karle Michael | 2 |
#9 | Bostrom Jonas | 1 |
#10 | Bostroem Jonas | 1 |
Publication | Filing date | Title |
---|---|---|
GB201820529D0 | Compounds and combinations for the treatment of rosacea | |
GB201721278D0 | Compunds and combinations for the treatment of rosacea | |
KR20170095839A | 3-(piperidin-4-yl)-isoxazol-3(2h)-ones for treatment of dermatologic disorders |